MEDI-570

N/A

Report date: 2023/05/05 17:35:25

Base Information

Drug NameMEDI-570
Drug Alias NameICOS inhibitors (Japan Tobacco/MedImmune)anti-ICOS monoclonal antibodies (Japan Tobacco/MedImmune)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionImmunomodulatorsInducible T-cell costimulator antagonists
TargetsInducible T-cell costimulator
Therapy Area/IndicationsLupus Erythematosus, SystemicMycosis FungoidesLymphoma, T-Cell, Cutaneous +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesMexico +[5] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesJapan Tobacco (Hong Kong) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer Institute
Inactive CompaniesAstrazeneca PlcMedimmune Llc
Active IndicationsMycosis FungoidesLymphoma, T-Cell, CutaneousLymphoma, T-Cell +[5] 
Inactive IndicationsLupus Erythematosus, Systemic

Other Information

ATC CodeN/A
Related LinksN/A